Revision requirement of tests to be administered for determining the presence of a heritable or congenital disorder

This bill requires Minnesota's health commissioner to periodically update the list of genetic tests used to screen for heritable or congenital disorders, ensuring the list reflects medical advances and improves public health. Specifically, it mandates adding metachromatic leukodystrophy (MLD) testing to the required screening panel. The revision process must consider factors like test accuracy, treatability of the disorder, and severity of health impacts. This directly affects newborns and infants in Minnesota who undergo routine screening, as well as healthcare providers administering these tests. The change is effective immediately upon the commissioner's revision, with no additional rulemaking requirements.